BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2930112)

  • 1. Right-sided staphylococcal endocarditis.
    Monane M; Gabelman GS; Cohen E; Karpel JP
    Ann Intern Med; 1989 May; 110(9):749-50. PubMed ID: 2930112
    [No Abstract]   [Full Text] [Related]  

  • 2. Right-sided Staphylococcus aureus endocarditis in intravenous drug abusers: two-week combination therapy.
    Chambers HF; Miller RT; Newman MD
    Ann Intern Med; 1988 Oct; 109(8):619-24. PubMed ID: 3421575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nafcillin-gentamicin synergism in experimental staphylococcal endocarditis.
    Sande MA; Courtney KB
    J Lab Clin Med; 1976 Jul; 88(1):118-24. PubMed ID: 1047088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective evaluation of therapies for Staphylococcus aureus endocarditis.
    Gentry CA; Rodvold KA; Novak RM; Hershow RC; Naderer OJ
    Pharmacotherapy; 1997; 17(5):990-7. PubMed ID: 9324187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Staphylococcus aureus bacteremia and endocarditis. New diagnostic and therapeutic concepts.
    Mortara LA; Bayer AS
    Infect Dis Clin North Am; 1993 Mar; 7(1):53-68. PubMed ID: 8463653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacterial endocarditis with a tolerant staphylococcal organism.
    McMillan JA; Weiner LB
    Clin Pediatr (Phila); 1982 Apr; 21(4):252-4. PubMed ID: 7067320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prosthetic valve endocarditis caused by Staphylococcus epidermidis. Development of rifampin resistance during vancomycin and rifampin therapy.
    Chamovitz B; Bryant RE; Gilbert DN; Hartstein AI
    JAMA; 1985 May; 253(19):2867-8. PubMed ID: 3989962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users.
    Small PM; Chambers HF
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1227-31. PubMed ID: 2393284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anaerobic endocarditis caused by Staphylococcus saccharolyticus.
    Westblom TU; Gorse GJ; Milligan TW; Schindzielorz AH
    J Clin Microbiol; 1990 Dec; 28(12):2818-9. PubMed ID: 2280017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of nafcillin, methicillin, and cephalothin in experimental Staphylococcus aureus endocarditis.
    Carrizosa J; Kobasa WD; Kaye D
    Antimicrob Agents Chemother; 1979 May; 15(5):735-7. PubMed ID: 525991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nafcillin-tolerant Staphylococcus epidermidis endocarditis.
    Arthur JD; Bass JW; Keiser JF; Harden LB; Brown SL
    JAMA; 1982 Jan 22-29; 247(4):487-8. PubMed ID: 6915109
    [No Abstract]   [Full Text] [Related]  

  • 12. Nafcillin therapy for Staphylococcus aureus endocarditis.
    Masur H; Murray HW; Roberts RB
    Antimicrob Agents Chemother; 1978 Sep; 14(3):457-61. PubMed ID: 708023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of streptococcal and staphylococcal endocarditis.
    Simmons N
    J Antimicrob Chemother; 1987 Sep; 20(3):447. PubMed ID: 3680081
    [No Abstract]   [Full Text] [Related]  

  • 14. An arm infection after abdominal gunshot wound.
    Ericsson C
    Hosp Pract (Off Ed); 1981 Aug; 16(8):136-9. PubMed ID: 6790407
    [No Abstract]   [Full Text] [Related]  

  • 15. Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to parenteral drugs and in nonaddicts: A prospective study.
    Korzeniowski O; Sande MA
    Ann Intern Med; 1982 Oct; 97(4):496-503. PubMed ID: 6751182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful therapy of experimental endocarditis caused by vancomycin-resistant Staphylococcus aureus with a combination of vancomycin and beta-lactam antibiotics.
    Fox PM; Lampen RJ; Stumpf KS; Archer GL; Climo MW
    Antimicrob Agents Chemother; 2006 Sep; 50(9):2951-6. PubMed ID: 16940087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative efficacy of amoxicillin-clavulanate, cloxacillin, and vancomycin against methicillin-sensitive and methicillin-resistant Staphylococcus aureus endocarditis in rats.
    Cantoni L; Wenger A; Glauser MP; Bille J
    J Infect Dis; 1989 May; 159(5):989-93. PubMed ID: 2708846
    [No Abstract]   [Full Text] [Related]  

  • 18. Abbreviated therapy for right-sided Staphylococcus aureus endocarditis in injecting drug users: the time has come?
    DiNubile MJ
    Eur J Clin Microbiol Infect Dis; 1994 Jul; 13(7):533-4. PubMed ID: 7805679
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacokinetics of nafcillin in obesity.
    Yuk J; Nightingale CH; Sweeney K; Levitz RE; Quintiliani R
    J Infect Dis; 1988 May; 157(5):1088-9. PubMed ID: 3361148
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of vancomycin in the treatment paradigm.
    Stevens DL
    Clin Infect Dis; 2006 Jan; 42 Suppl 1():S51-7. PubMed ID: 16323121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.